GT Biopharma
GTBP • NASDAQ
GT Biopharma is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Michael Martin Breen, with a market cap of $12.3M.
Market Cap$12.3M
Employees2.0
CEOMichael Martin Breen
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 14, 2026 · in a monthQ1 2026
Financials
GTB
GT Biopharma FAQ
Common questions about GT Biopharma
GT Biopharma is scheduled to report earnings for Q1 2026 on May 14, 2026.
GT Biopharma has approximately 2 employees.